Share on LinkedInShare on LinkedIn

ARTICLE · 03 APRIL 2020

COVID-19 And Shareholders Meetings: Now What?

We have received several inquiries from clients asking for guidance regarding their shareholders meetings in light of the rapidly evolving novel coronavirus ("COVID-19") pandemic and the need...

CanadaCoronavirus (COVID-19)

We have received several inquiries from clients asking for guidance regarding their shareholders meetings in light of the rapidly evolving novel coronavirus ("COVID-19") pandemic and the need to socially distance ourselves. With the annual general shareholder meeting ("AGM") season upon us, this article seeks to provide information relating to (i) the options available for holding AGMs in light of the COVID-19 concerns and (ii) the procedures to be followed in the event that an issuer decides to change the date, time or location of its in person AGM due to COVID-19.

We note that the discussion in this article relates to business transacted at AGMs (for example, election of directors and amendments to equity incentive plans). Issuers involved in proxy contests, holding special meetings for merger and acquisition transactions, or obtaining securityholder approval for transactions under Multilateral Instrument 61-101 Protection of Minority Securityholders in Special

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from